Ketamine and esketamine: key considerations

Go back to Messenger

November Messenger 2020, Prescribing | Posted November 17, 2020

View the clinical toolkit.

Comments for this post are now closed. If you would like to share your feedback on this topic, please email support@cpsa.ca.

Related News

All News & Events

November 13, 2025

Reviewing your 2025 MD Snapshot report and dashboard

Explore your updated MD Snapshot-Prescribing report and Practice Checkup dashboard! Plus, complete the survey for a chance to win an Apple Watch!

MD Snapshot-Practice Checkup, MD Snapshot-Prescribing, November Messenger 2025, Prescribing

August 14, 2025

Explore the updated TPP Alberta Drug Utilization Atlas

Check out the latest version of our online prescribing resource.

August Messenger 2025, Prescribing

August 8, 2024

Review the principles of safe opioid prescribing and earn CPD credits

July 11, 2024

Should we add a risk model score to MD Snapshot-Prescribing?

July 11, 2024

TPP Alberta launches an interactive online atlas

June 13, 2024

TPP-monitored drug forgeries and lost or stolen TPP prescription pads

Innovation at CPSA

We are the only medical regulator in Canada with an in-house Analytics, Innovation & Research (AIR) team. Learn how CPSA's regulatory-based research supports quality medical practice.